Despite a plethora of compelling evidence supporting sodium-glucose cotransporter 2 (SGLT2) inhibitors for patients with Type 2 diabetes and chronic kidney disease (CKD), many eligible patients still do not receive them.
VA Study Finds No Link Between GLP-1 RA Use, Risk of Hematologic Malignancies
Glucagon-like peptide-1 receptor agonists (GLP-1RA) are widely used for the management of diabetes mellitus and obesity, but is there a link between their use and a greater risk of hematologic malignancies?
GLP-1RAs Don’t Work Better Than Oral Agents to Enable Insulin Discontinuation in T2D
With all of the hype surrounding glucagon-like peptide-1 receptor agonists (GLP-1RAs) for Type 2 diabetes, some proponents have questioned whether patients using the drugs could eventually discontinue their use of insulin for glucose control.
In VA EDs, Female Physician Slightly More Likely to Order Scans, Tests and Admit Patients
Female and male physicians have different practice patterns, according to past studies mainly focused on primary care.
Diabetes Staging System Improves Care for Type 2 Diabetes Patients In VA Primary Care Clinics
Guideline-concordant care for veteran Type 2 diabetes (T2D) patients improved with use of the Diabetes Staging System to guide treatment, predict survival and create a shared language for care in VA primary care clinics.
Younger Veterans With Insomnia/Sleep Apnea Combo Have High Risk of Type 2 Diabetes
The combination of insomnia and obstructive sleep apnea can be a dangerous combination for U.S. veterans, resulting in a much higher risk of Type 2 diabetes, among other conditions.
Diabetes Staging System Improves Care for Type 2 Diabetes Patients In VA Primary Care Clinics
Guideline-concordant care for veteran Type 2 diabetes (T2D) patients improved with use of the Diabetes Staging System to guide treatment, predict survival and create a shared language for care in VA primary care clinics.
Video Telemedicine Might Match In-Person Diabetes Care Outcomes in Veterans
Telemedicine has become an important tool for managing chronic diseases such as diabetes, particularly for patients facing geographic, mobility or scheduling barriers to specialty care. But new research from the VA suggests outcomes may differ, depending on how remote diabetes specialty care is delivered.
CGM Data Predicts Kidney Decline, Cuts ESRD Risk in VA Diabetes Studies
VA researchers also find TBI doubles dementia risk in type 2 diabetes; stress tied to diabetes onset; and metformin linked to slower biological aging
Minor Amputation Signals Ongoing Risk for Limb Loss in Veterans With Diabetes and PAD
Veterans with diabetes and peripheral arterial disease (PAD) are at substantial risk for limb loss—even after undergoing procedures that are often considered limb-sparing.
GLP‑1 Drugs, Healthy Lifestyle Together Appear to Reduce CVD Risk
In Type 2 diabetes patients, use of GLP‑1 drugs combined with healthy lifestyle habits is associated with reduced risk of major adverse cardiovascular events.
Indian Health Service Weathered Shutdown OK, but Weaknesses Still Threaten Its Mission
During the 2018 government shutdown, the Indian Health Service was forced to cut tribal services, burned through medical supplies it had on hand and opened discussions into closing some facilities.
Adjusting Glycemic Goals as Veterans Age Improves Outcomes From Diabetes
The VA serves more patients with diabetes than any other healthcare system in the United States. Many of these veterans are older adults with multiple comorbidities, increasing their risk for both hyperglycemia-related complications and serious consequences of hypoglycemia.
Selecting Diabetes Medications: Which GLP-1RAs Are Safest, Most Effective?
The medication class glucagon-like peptide-1 receptor agonists (GLP-1RAs) might be at the center of discussion in medicine these days, but a new study pointed out that the comparative effectiveness and safety of individual formulations have not been well understood.
Adding Telehealth to In-Person Care Benefits Older Diabetes Patients
Limited studies of telehealth in chronic disease management include older adults with diabetes mellitus, according to a new study.
Small MHS Drug Co-Payment Increase Had Little Effect on Diabetes Patients, Others
How did a copayment increase instituted Feb. 1, 2018, for beneficiaries covered by the retail or mail order Military Health System (MHS) pharmacy benefit affect medication use?
COVID-19 Mortality Originally Higher for Veterans With Diabetes; Less So Now
Early in the COVID-19 pandemic, veterans with diabetes had a higher risk of dying within two months after infection, compared to veterans without diabetes. Those risks had generally evened out by mid-2022, however, according to a new study.
CGM Enhances VA Diabetes Care, but GMI Might Mislead Clinicians
Nearly 1 in 4 veterans receiving care through the VA lives with diabetes—more than twice the prevalence in the general U.S. population—putting them at risk for cardiovascular complications such as stroke, peripheral artery disease and amputations as well as chronic kidney disease, cognitive impairment, diabetic retinopathy and glaucoma, among other conditions.
Insulin Resistance Surrogates Linked to Greater Small Cell Lung Cancer Risk
Insulin resistance (IR) has shown correlation with increased cancer risk, but few studies have explored the relationship between IR and small cell lung cancer (SCLC), according to a new Chinese study.
Veteran Studies Suggest That CGM Use Reduced Mortality in Diabetes Patients
Are metrics derived from continuous glucose monitoring more predictive of all-cause mortality in diabetes patients than standard blood tests such as hemoglobin A1C?
A Third of Type 1 Diabetes in Adults Misdiagnosed; Adult-Onset Increasing at VA, Elsewhere
A new review looked at adult-onset Type 1 diabetes and methods to improve screening and diagnosis.
Comorbid PTSD, Diabetes Worsens Veterans Long-Term Functioning, Disability
U.S. veterans with comorbid diabetes and post-traumatic stress disorder (PTSD) had poorer function and greater disability compared to those with neither condition or only one of the conditions, according to a new study.
Hypercortisolism: A Hidden Factor in Difficult-to-Control Type 2 Diabetes
Despite the growing arsenal of glucose-lowering medications, many patients with Type 2 diabetes still struggle to achieve adequate blood glucose control.
Subcutaneous Insulin Found to Be Safe Alternative for Moderate Diabetic Ketoacidosis
In adults with mild to moderate diabetic ketoacidosis, a complication of diabetes, subcutaneous insulin may be a safe and equally effective treatment compared to traditional intravenous insulin infusion, according to a recent review article.
Increasing Prescribing of SGLT2is, GLP-1 RAs in High-Risk VA Diabetes Patients
Within the VA, there is limited prescribing of SGLT2 inhibitors and GLP-1 RAs for diabetes management in high-risk veteran patients, but a new intervention directed at healthcare providers has been found to improve prescribing rates, according to a recent study.
A Third of Type 1 Diabetes in Adults Misdiagnosed
A new review looked at adult-onset Type 1 diabetes and methods to improve screening and diagnosis.
New-Onset Diabetes After COVID-19 Infection Likely to Go Into Remission
As researchers continue to investigate the long-term effects of SARS-CoV-2, a new study utilizing VA data has uncovered an intriguing pattern: Individuals who developed new-onset diabetes after a COVID-19 infection were more likely to experience diabetes remission.
Automated Insulin Delivery Safe, Effective for Type 2 Diabetes
Automated insulin delivery (AID) outperformed continuous glucose monitoring alone in Type 2 diabetes patients treated with insulin, according to a new study.
SGLT2i Use Linked to Higher Risk of Amputations in Diabetes Patients
More than 30 million U.S. adults—including approximately 25% of veterans—have diabetes, putting them at increased risk of heart disease.
Large Analysis of Veterans With Diabetes: More Benefits with GLP-1RA, Especially Neurological
While glucagon-like peptide-1 receptor agonists (GLP-1RA) are known to successfully treat diabetes and aid weight loss, they also have other widespread benefits, including for cognitive and behavioral health.